OTHER INFORMATION
−Removed: During the three months ended September 30, 2025 , no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
−Removed: On July 11, 2025, two short term promissory notes of $150 thousand each were issued by the Company’s majority-owned subsidiary KardioNav to David Jenkins, the Company's Chairman of the Board and Chief Executive Officer, and Lifestim, Inc., a company controlled by Mr.
−Removed: Jenkins, in exchange for an aggregate loan of $300 thousand.
−Removed: The promissory notes have a maturity date of July 11, 2026, and interest rates of 4.2% per annum, with all principal and interest payable upon maturity.
−Removed: As of September 30, 2025, $300 thousand of principal was outstanding on the notes.
−Removed: The notes, including all principal and interest, accelerate and become immediately due and payable upon the occurrence of certain customary events of default, including failure to pay amounts owed when due, material breach of the Company’s representations or warranties (unless waived by the holders or cured within 10 days following notice), certain events involving the discontinuation of the Company’s business and/or certain types of proceedings involving insolvency, bankruptcy, receivership and the like.
+Added: During the three months ended March 31, 2026 , no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
Incorporated by Reference
10 unchanged sentences
Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 10/17/2025)
−Removed: Certificate of Designation of Series X Convertible Preferred Stock.
Certificate of Designation of Series A Preferred Stock.
Certificate of Designation of Series B Preferred Stock.
+Added: Certificate of Designation of Series C-1 Preferred Stock
+Added: Certificate of Amendment of Certificate of Designations of Series C-1 Preferred Stock
+Added: Certificate of Designation of Series C-2 Preferred Stock
+Added: Certificate of Designation of Series D Preferred Stock
+Added: Certificate of Designation of Series J Preferred Stock
+Added: Certificate of Correction of Certificate of Designation of Series J Preferred Stock
+Added: Certificate of Designation of Series X Convertible Preferred Stock.
Amended and Restated Bylaws of the Registrant.
Amendment to Amended and Restated Bylaws of the Registrant.
−Removed: Specimen common stock certificate of the Registrant.
−Removed: Form of Series B Warrant offered in February 2022.
−Removed: Form of Series C Warrant issued in July 2022
−Removed: Warrant Agency Agreement, dated February 8, 2022, by and between the Registrant and American Stock & Trust Company LLC.
−Removed: Amendment No.
−Removed: 1, dated July 22, 2022, to February 8, 2022 Warrant Agency Agreement by and between the Company and American Stock Transfer & Trust Company, LLC.
−Removed: Form of Series I common stock Warrant issued September 2024
−Removed: Form of Series J common stock Warrant issued September 2024
−Removed: Form of Series K Warrant issued October 2024
−Removed: Form of Placement Agent Warrant offered in October 2024
−Removed: Form of Underwriters' Warrant offered in September 2024
−Removed: Form of Warrant Agency Agreement dated as of September 3, 2024 entered into by and between the Registrant and Equiniti Trust Company, LLC
−Removed: Form of Series L Warrant offered in May 2025.
−Removed: Short Term Promissory Note dated July 11, 2025 by and between KardioNav, Inc.
−Removed: Short Term Promissory Note dated July 11, 2025 by and between KardioNav, Inc.
−Removed: and Lifestim, Inc.
+Added: Securities Purchase Agreement, dated February 6, 2026, by and among the Company and the investor signatory thereto
+Added: Securities Purchase Agreement, dated February 6, 2026 by and among the Company and SEG Jets LLC
+Added: Registration Rights Agreement, dated February 6, 2026 by and among the Company and the investor signatory thereto
+Added: Series J Exchange Agreement dated February 12, 2026 between the Company and David A.
+Added: Series J Exchange Agreement dated February 12, 2026 between the Company and FatBoy Capital, L.P.
+Added: Securities Purchase Agreement, dated March 9, 2026, by and among the Company and the investors signatory thereto
+Added: Stock Purchase Agreement, dated March 9, 2026, by and among the Company and the investors signatory thereto
+Added: Registration Rights Agreement, dated March 9, 2026, by and among the investors signatory thereto
+Added: Secured Promissory Note dated February 27, 2025 by and between Creatd, Inc.
+Added: and Marc Sellouk
+Added: Exclusive Aircraft Dry Lease Agreement dated September 9, 2025 by and between SEG Jets, LLC and Ponderosa Air, LLC
+Added: Exclusive Aircraft Dry Lease Agreement dated February 11, 2026 by and between SEG Jets, LLC and Ponderosa Air, LLC
+Added: Exclusive Aircraft Dry Lease Agreement dated March 16, 2026 by and between SEG Jets, LLC and Ponderosa Air, LLC
+Added: Form of Unsecured 10% Discount Convertible Note by and among Flewber Global, Inc.
+Added: and the holders thereto
+Added: Form of Unsecured Convertible Note by and among Flewber Global, Inc.
+Added: and the holders thereto
+Added: Form of Unsecured Subordinated Promissory Note by and among Flewber Global, Inc.
+Added: and the holders thereto
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
CATHETER PRECISION, INC.
−Removed: November 13, 2025
Executive Chairman of the Board and
1 unchanged sentence
(Principal Executive Officer)
−Removed: November 13, 2025
/s/ Philip Anderson
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.